Atlas Trials

Evaluate the Effects on Asthma Control of Rabeprazole Given Twice Daily in Subjects With Asthma.

Clinical trial NCT00214552 · COMPLETED

Trial details

NCT number
NCT00214552
Sponsor
Associated Scientists to Help Minimize Allergies
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
AsthmaGastroesophageal Reflux Disease
Start date
2002-09-01
Primary completion
2005-03-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.